OTCPK:ZMSP.F

Stock Analysis Report

Executive Summary

Zecotek Photonics Inc., a photonics technology company, develops various photonics technologies and products for commercial and research applications in medical, bio-science, high-energy physics, pharmaceutical research, material processing, engineering and industrial design, and multi-media markets.

Snowflake

Fundamentals

Worrying balance sheet with weak fundamentals.

Risks

  • Zecotek Photonics has significant price volatility in the past 3 months.
  • Zecotek Photonics is not covered by any analysts.

Share Price & News

How has Zecotek Photonics's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

2.3%

OTCPK:ZMSP.F

1.5%

US Medical Equipment

0.8%

US Market


1 Year Return

-84.4%

OTCPK:ZMSP.F

9.7%

US Medical Equipment

1.9%

US Market

ZMSP.F underperformed the Medical Equipment industry which returned 9.6% over the past year.

ZMSP.F underperformed the Market in United States of America which returned 2.1% over the past year.


Share holder returns

ZMSP.FIndustryMarket
7 Day2.3%1.5%0.8%
30 Day-25.3%0.7%3.4%
90 Day-40.8%2.4%2.1%
1 Year-84.4%-84.4%10.6%9.7%4.2%1.9%
3 Year-91.3%-91.3%70.2%65.0%46.7%37.2%
5 Year-95.6%-95.6%136.0%109.1%62.3%44.5%

Price Volatility Vs. Market

How volatile is Zecotek Photonics's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Zecotek Photonics undervalued based on future cash flows and its price relative to the stock market?


In this section, we usually try to help investors determine whether Zecotek Photonics is trading at an attractive price based on the cash flow it is expected to produce in the future. But as Zecotek Photonics has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions.

This is quite a rare situation as 89% of companies covered by Simply Wall St do have a valuation analysis.


Next Steps

  • Take a look at our analysis of ZMSP.F’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  • When valuing a company like this, investors focus more on how they perceive the size of the opportunity, the company's ability to deliver and scale, and the strength of the team. While we are not analysing this type of data at the moment, if you don’t know where to start, we recommend reading through Zecotek Photonics regulatory filings here.
  • Explore potentially undervalued companies in the Healthcare industry.

Future Growth

How is Zecotek Photonics expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

22.1%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Zecotek Photonics has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

  • Take a look at our analysis of ZMSP.F’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  • While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on the OTC Markets Website. If you are looking for more of a qualitative research into the company, you can access Zecotek Photonics's filings and announcements here.
  • Explore growth companies in the Healthcare industry.

Past Performance

How has Zecotek Photonics performed over the past 5 years?

17.5%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Zecotek Photonics does not make a profit even though their year on year earnings growth rate was positive over the past 5 years.

Unable to compare Zecotek Photonics's 1-year earnings growth to the 5-year average as it is not currently profitable.

Unable to compare Zecotek Photonics's 1-year growth to the US Medical Equipment industry average as it is not currently profitable.


Return on Equity

It is difficult to establish if Zecotek Photonics has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) due to its liabilities exceeding its assets.


Return on Assets

It is difficult to establish if Zecotek Photonics has efficiently used its assets last year compared to the US Medical Equipment industry average (Return on Assets) as it is loss-making.


Return on Capital Employed

It is difficult to establish if Zecotek Photonics improved its use of capital last year versus 3 years ago (Return on Capital Employed) due to its liabilities exceeding its assets.


Next Steps

Financial Health

How is Zecotek Photonics's financial position?


Financial Position Analysis

Zecotek Photonics's short term (1 year) commitments are greater than its holdings of cash and other short term assets.

Zecotek Photonics has no long term commitments.


Debt to Equity History and Analysis

Zecotek Photonics has negative shareholder equity (liabilities exceed assets), this is a more serious situation compared with a high debt level.

Irrelevant to check if Zecotek Photonics's debt level has increased considering it has negative shareholder equity.


Balance Sheet

High level of physical assets or inventory.

Zecotek Photonics has negative shareholder equity (liabilities exceed assets) therefore debt is not covered by short term assets.


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Zecotek Photonics has less than a year of cash runway based on current free cash flow.

Zecotek Photonics has less than a year of cash runway if free cash flow continues to grow at historical rates of 26.3% each year.


Next Steps

Dividend

What is Zecotek Photonics's current dividend yield, its reliability and sustainability?


Dividend Yield and Payments Analysis

Unable to evaluate Zecotek Photonics's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.

Unable to evaluate Zecotek Photonics's dividend against the top 25% market benchmark as the company has not reported any payouts.

Unable to perform a dividend volatility check as Zecotek Photonics has not reported any payouts.

Unable to verify if Zecotek Photonics's dividend has been increasing as the company has not reported any payouts.


Current Payout to Shareholders

Unable to calculate sustainability of dividends as Zecotek Photonics has not reported any payouts.


Future Payout to Shareholders

Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.


Next Steps

Management

What is the CEO of Zecotek Photonics's salary, the management and board of directors tenure and is there insider trading?

10.4yrs

Average management tenure


CEO

A. Zerrouk 0

14.7yrs

Tenure

CA$632,558

Compensation

Dr. A. Faouzi Zerrouk is the Founder of Zecotek Photonics Inc and has been its Chairman, President and Chief Executive Officer since December 31, 2004. Dr. Zerrouk Principal Founder of Zecotek Holdings Ltd ...


CEO Compensation Analysis

A.'s remuneration is about average for companies of similar size in United States of America.

A.'s compensation has been consistent with company performance over the past year, both up more than 20%.


Management Age and Tenure

10.4yrs

Average Tenure

The average tenure for the Zecotek Photonics management team is over 5 years, this suggests they are a seasoned and experienced team.


Board Age and Tenure

11.8yrs

Average Tenure

The average tenure for the Zecotek Photonics board of directors is over 10 years, this suggests they are a seasoned and experienced board.


Insider Trading

No 3 month open market individual insider trading information.


Ownership Breakdown


Management Team

  • Shirley Kancs (66yo)

    Assistant Secretary

    • Tenure: 0yrs
    • Compensation: CA$21.67k
  • A. Zerrouk

    Founder

    • Tenure: 14.7yrs
    • Compensation: CA$632.56k
  • Zair Sadygov

    Chief Scientist of Medical Imaging Division

    • Tenure: 12.5yrs
  • Serge Khorev

    Senior Vice President of Technology

    • Tenure: 8.3yrs
  • Jiang Chen

    Chief Financial Officer

    • Tenure: 0.7yrs

Board Members

  • Erich Sager (61yo)

    Independent Director

    • Tenure: 14.7yrs
    • Compensation: CA$24.00k
  • A. Zerrouk

    Founder

    • Tenure: 14.7yrs
    • Compensation: CA$632.56k
  • Thomas Lewellen

    Member of Scientific Advisory Board

    • Tenure: 0yrs
  • Tiong-Ann Teoh

    Member of Scientific Advisory Board

    • Tenure: 11.8yrs
  • Zelong He

    Director

    • Tenure: 0.8yrs
  • Sergy Tsakunov

    Director

    • Tenure: 0.8yrs

Company Information

Zecotek Photonics Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Zecotek Photonics Inc.
  • Ticker: ZMSP.F
  • Exchange: OTCPK
  • Founded: 1983
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: CA$4.123m
  • Listing Market Cap: CA$3.111m
  • Shares outstanding: 164.93m
  • Website: https://www.zecotek.com

Location

  • Zecotek Photonics Inc.
  • 21331 Gordon Way
  • Unit 1120
  • Richmond
  • British Columbia
  • V6W 1J9
  • Canada

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
W1IDB (Deutsche Boerse AG)YesCommon SharesDEEURSep 1988
ZMSP.FOTCPK (Pink Sheets LLC)YesCommon SharesUSUSDSep 1988
ZMSTSXV (TSX Venture Exchange)YesCommon SharesCACADSep 1988

Biography

Zecotek Photonics Inc., a photonics technology company, develops various photonics technologies and products for commercial and research applications in medical, bio-science, high-energy physics, pharmaceu ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/09/18 00:26
End of Day Share Price2019/09/16 00:00
Earnings2019/04/30
Annual Earnings2018/07/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.